Meghann Smith
Prior to joining Ockham, Smith was a senior member of the management team in charge of oversight and risk mitigation strategies in all phases of study development at PPD.
Ockham’s CEO, James Baker said: "As Ockham continues to expand its Oncology experience, we are pleased to have Meghann join our group.
“Meghann will provide additional value to our current and potential clients as we help navigate them through the Oncology clinical trial process."